Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)Therapy for Social Anxiety Disorder

NCT ID
NCT07772401
Registry status
Recruiting
Study type
Interventional
Phase
Not applicable
Sponsor
Second Affiliated Hospital, Zhejiang University, School of Medicine
Conditions
Social Anxiety Disorder, Social Fear

Overview

ClinicalTrials.gov lists this study as Recruiting.

Official title: Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)for Social Anxiety Disorder: A Randomized Controlled Clinical Trial.

Enrollment: 50 participants (Estimated).

What is being studied

  • Device: sham-taVNS
  • Device: taVNS

Who may be eligible

Ages
18 Years to 70 Years
Sex
All
Healthy volunteers accepted
No

ClinicalTrials.gov lists the following eligibility criteria.

Inclusion Criteria: Fulfillment of the DSM-5 diagnostic criteria for Social Anxiety Disorder (SAD). A Liebowitz Social Anxiety Scale (LSAS) score of ≥30 and a Clinical Global Social Phobia Inventory score greater than 30 Age between 18 and 70 years. Voluntary provision of written informed consent. Exclusion Criteria: A lifetime history of bipolar disorder, schizophrenia, or obsessive-compulsive disorder. Any cognitive impairments that could interfere with the study. Significant suicidal ideation or behavior within the past six months. Patients with rapidly deteriorating conditions. Previous taVNS treatment within the past month. Contraindications to auricular vagus nerve stimulation, such as ear infections, inflammation, skin lesions, or hypersensitivity of the ear. Presence of a pacemaker or other implanted medical devices, or severe neurological, renal, cardiovascular, or hepatic diseases. Concurrent engagement in any form of psychotherapy. History of psychotropic medications or alcohol abuse. Inability to comply with psychological assessments. Incapable of providing informed consent. Pregnant or lactating. Other reasons as deemed unsuitable for inclusion by the research team.

Study locations

1 study location is listed.

Recruiting site status is explicitly provided for 1 location; 0 are listed as Recruiting.

Countries: China

  • Zhejiang, China: 1

Sample of listed locations

  • The Second Affiliated Hospital Zhejiang University School of Medicine — Hangzhou, Zhejiang, 311500, China — Not yet recruiting

Study details

Start date
May 5, 2026
Primary completion date
October 1, 2026
Completion date
December 1, 2026
First posted
August 19, 2026

Source and update information

Source
ClinicalTrials.gov
NCT ID
NCT07772401
Registry last updated
October 2, 2026
QualifiedStudies registry data refreshed
October 5, 2026
QualifiedStudies record fetched
October 5, 2026

View NCT07772401 on ClinicalTrials.gov

Trial information can change. Confirm current study details with the study team or the registry.

About joining clinical research

Find clinical trials you may match with

QualifiedStudies can help you search for research opportunities related to your health. Availability of this specific study through QualifiedStudies has not been established.

Find clinical trials you may match with | Anxiety studies | Clinical trial FAQ